Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » Subscription Plans

Subscription Plans


ChinaBio® Today - covering the China life science industry... 

China is already the fastest growing market in the world for pharmaceuticals and medical devices. Now, after billions of dollars of government and private investment, China is also becoming a world leader in innovation.

ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market.

Subscriber Benefits

As a Premium Subscriber you will have full access to all current articles plus over 2500 archived articles covering key events and companies in China's life science industry.  Our exclusive content is written by our in-house team of dedicated researchers and editors includes daily articles covering topics like:

    • News & Analysis
    • Featured Companies
    • Industry Insights
    • Deals & Financings
    • Trials & Approvals
    • Government & Regulatory
    • Legal & IP Issues
    • Stock Watch

And many other topics of interest.  And all of our subscribers also receive daily or weekly email updates with a quick summary of the key events in China biotech.

The Premium Subscription Plan is only $20/month. And you can cancel at any time.

Getting Started

Join our over 20,000 readers and start receiving all the benefits of our Premium subscription plan today.

Subscribe Now

Recent Articles

  WuXi PharmaTech's Shanghai Lab Certified for Genomic Screening